“When patients come to a specialized clinic like mine, they’ve usually had the disease for five to ten years and have seen ten, twenty, different physicians. That’s the typical journey of a patient with prurigo nodularis.”
Dr. Martin Metz, MD, Deputy Director, Institute of Allergology Charite Universitatsmedizin, Berlin
Prurigo nodularis is a chronic skin disease linked to the nervous and immune systems that remains under-recognized despite its profound impact on patients’ lives.1-6 The intensely itchy, firm nodules can cause a lot of physical discomfort, emotional distress, and social withdrawal.2,7-9 Yet, for many patients, the journey to diagnosis is long and fraught with uncertainty, often marked by misinterpretation of symptoms and delays in receiving appropriate care.10,11
Setting off
Despite the visible signs, the road to a correct diagnosis can have many hurdles. Often, patients see several doctors over the course of many years before receiving a definitive diagnosis.10,11 The nuanced nature of prurigo nodularis symptoms – ranging from itch intensity to lesion distribution – can make diagnosis particularly challenging.10,11
Additionally, historical misconceptions of symptoms such as chronic scratching have been misunderstood as behavioral or psychological issues, rather than signs of a physical disease.12 This misinterpretation can compound emotional distress, leaving patients feeling isolated and invalidated.10-12
Delays and diversions
The rarity and lack of widespread awareness of prurigo nodularis means that many doctors may be unfamiliar with its presentation. Combined with the varying symptoms and potential overlap with other skin conditions, this can delay referrals, diagnosis, and treatment.10-12
This lack of familiarity contributes to a fragmented patient experience, where individuals may be treated for symptoms without a clear understanding of the root cause. As a result, patients often endure years of trial-and-error and growing discomfort before reaching a specialist.10-12
Changing gears
Initiatives such as World Prurigo Day play a vital role in raising awareness and encouraging conversations amongst doctors, researchers, and patients, to help to break down misconceptions and promote earlier diagnosis and treatment.
Recent research has also begun to reshape understanding of prurigo nodularis. It is now recognized as a condition, with unique interactions between the nervous and immune systems, reinforcing the need for targeted approaches to care.1,13
Prurigo nodularis: Diagnosis and disease management
Finding a new route
Historically, treatment options for prurigo nodularis were limited. Today, the landscape is changing, and new targeted therapies offer hope for improved disease control.1
Commenting on the importance of a varied treatment landscape, Dr. Metz said: “It’s always good to have treatment options with different targets or mechanisms of action, because there may be different factors involved that are unique to the patient. This is why it’s important to have different tools in your toolbox that you can use based on the patient’s individual circumstances.”
A map to higher ground
Despite progress, there is still much to be done to improve the prurigo nodularis care pathway, including continued funding for research to better understand the disease and uncover ways to treat it, and expanded awareness for both patients and doctors – particularly in primary care and dermatology – to support earlier recognition and referral, and ensure that patients receive timely and appropriate care.
By addressing these gaps, the healthcare community can move toward a more informed and compassionate approach to prurigo nodularis management.
Reaching Our Destination
We remain committed to supporting the prurigo nodularis community; amplifying patient voices, driving innovation in treatment development, educating clinicians, and fostering a future where no one has to navigate this complex disease alone.
This content is for informational purposes and is not intended as medical advice. If you or someone close to you are/is experiencing symptoms or need(s) more information on prurigo nodularis, please consult a qualified healthcare professional for personalized guidance.
References
- Kwatra SG. Breaking the itch–scratch cycle in prurigo nodularis. N Engl J Med. 2020;382(8): 757-758. doi: 10.1056/NEJMe191673
- Bewley A, et al. Prurigo Nodularis: A Review of IL-31RA Blockade and Other Potential Treatments. Dermatol Ther (Heidelb). 2022;12(9): 2039–2048. doi: 10.1007/s13555-022-00782-2
- Ständer S, et al. Prevalence of prurigo nodularis in the United States of America: a retrospective database analysis. JAAD Int. 2020;2: 28-30. doi: 10.1016/j.jdin.2020.10.009
- Huang AH, et al. Real-world prevalence of prurigo nodularis and burden of associated diseases. J Invest Dermatol. 2020;140(2): 480-483.e4. doi: 10.1016/j.jid.2019.07.697
- Huang AH, et al. Prurigo nodularis: epidemiology and clinical features. J Am Acad Dermatol. 2020;83(6): 1559-1565. doi: 10.1016/j.jaad.2020.04.183
- Pereira MP, et al. European Academy of Dermatology and Venereology European prurigo project: expert consensus on the definition, classification and terminology of chronic prurigo. J Eur Acad Dermatol Venereol. 2018;32(7): 1059-1065. doi: 10.1111/jdv.14570
- Huang AH, et al. Prurigo nodularis: epidemiology and clinical features. J Am Acad Dermatol. 2020;83(6): 1559-1565. doi: 10.1016/j.jaad.2020.04.183
- Joel MZ, et al. Risk of itch-induced sleep deprivation and subsequent mental health comorbidities in patients with prurigo nodularis: A population-level analysis using the Health Improvement Network. JAAD Int. 2023;13: 39-45
- Todberg T, et al. Treatment and burden of disease in a cohort of patients with prurigo nodularis: A survey-based study. Acta Derm Venerol. 2020;100:adv00119
- Kwatra SG, et al. Prurigo nodularis: disease burden, clinical features and approach to management. Br J Dermatol. 2025;193(4): 642-652. doi:10.1093/bjd/ljaf213.
- MyPrurigoTeam: How is prurigo nodularis diagnosed? Available online. Accessed December 2025
- Schneider G, et al. Psychological factors in prurigo nodularis in comparison with psoriasis vulgaris: results of a case-control study. Br J Dermatol. 2006;154: 61–66. doi: 10.1111/j.1365-2133.2005.06852.x
- Ständer S, et al. IFSI-guideline on chronic prurigo including prurigo nodularis. Itch. 2020;5(4):e42. doi: 10.1097/itx.0000000000000042